To identify the mechanisms underlying the radiosensitizing effect of a combined Hsp90 and HSF-1 inhibition in lung cancer cells, cell cycle phase distribution, apoptosis, and DNA damage response were analyzed. The gene discussed is HSF1; the disease is lung cancer.